Cargando…

A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive, malignant cancer with a complex pathogenesis. However, effective therapeutic targets and prognostic biomarkers are limited. Sorafenib provides delaying cancer progression and survival improvement in advanced HCC. But despite 10 years of re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Senbang, Chen, Wenjun, Chen, Tingting, Zuo, He, Bi, Ziran, Zhang, Xiuqing, Pang, Lulian, Jing, Yanyan, Yin, Xiangxiang, Cheng, Huaidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938566/ https://www.ncbi.nlm.nih.gov/pubmed/36803349 http://dx.doi.org/10.1186/s12876-023-02672-z

Ejemplares similares

Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma
por: Yao, Senbang, et al.
Publicado: (2021)

Exploring ALDH2 expression and immune infiltration in HNSC and its correlation of prognosis with gender or alcohol intake
por: Yao, Senbang, et al.
Publicado: (2022)

Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic
por: Pang, Lulian, et al.
Publicado: (2023)

Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels
por: Pang, Lulian, et al.
Publicado: (2023)

The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors
por: Zhang, Xiuqing, et al.
Publicado: (2022)

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients
por: Li, Wen, et al.
Publicado: (2022)

Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
por: Yao, Senbang, et al.
Publicado: (2023)

The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients
por: Yu, Sheng, et al.
Publicado: (2022)

The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values
por: Yao, Senbang, et al.
Publicado: (2022)

Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
por: Ding, Ke, et al.
Publicado: (2020)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy
por: Yao, Senbang, et al.
Publicado: (2022)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Re: Response to In regard to Ding et al. 2020: “Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors”
por: Cheng, Huaidong, et al.
Publicado: (2023)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

The Pro-Tumor Biological Function of IL-36α Plays an Important Role in the Tumor Microenvironment of HCC
por: Song, Yanmei, et al.
Publicado: (2023)

Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC
por: Cao, Jun, et al.
Publicado: (2022)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
por: Pang, Lulian, et al.
Publicado: (2022)

Siglecs in Brain Function and Neurological Disorders
por: Siddiqui, Shoib Sarwar, et al.
Publicado: (2019)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14
por: Murch, Simon H.
Publicado: (2020)

dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
por: Chu, Yen-Wei, et al.
Publicado: (2020)

Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus
por: Ali, Syed Raza, et al.
Publicado: (2014)

Comparison of (68)Ga-DOTA-Siglec-9 and (18)F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry
por: Virtanen, Helena, et al.
Publicado: (2017)

Ablation of Siglec-E augments brain inflammation and ischemic injury
por: Li, Lexiao, et al.
Publicado: (2022)

Selective Response to Bacterial Infection by Regulating Siglec-E Expression
por: Wu, Yin, et al.
Publicado: (2020)

Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
por: Zhuang, Yan, et al.
Publicado: (2022)

Role of Siglec-7 in Apoptosis in Human Platelets
por: Nguyen, Kim Anh, et al.
Publicado: (2014)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Discovery, Function, and Therapeutic Targeting of Siglec-8
por: Youngblood, Bradford A., et al.
Publicado: (2020)

The Role of Siglec-G on Immune Cells in Sepsis
por: Royster, William, et al.
Publicado: (2021)

CD24-Siglec interactions in inflammatory diseases
por: Liu, Yang, et al.
Publicado: (2023)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_agvvcn0aff39ie4rq9ipsh70og